1.61

6.62% 0.10

Biofrontera Inc (BFRI)

Overview News Price History Financials Discussions Forecast Stock Split

Biofrontera Inc stock is traded at $1.61, with a volume of 630.61K. It is up +6.62% in the last 24 hours and up +31.97% over the past month. Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Previous Close:

$1.51

Open:

$1.52

24h Volume:

630.61K

Relative Volume:

1.80

Market Cap:

$23.91M

Revenue:

$43.20M

Net Income/Loss:

$-11.09M

P/E Ratio:

-1.452

EPS:

-1.1088

Net Cash Flow:

$-9.32M

1W Performance:

+1.26%

1M Performance:

+31.97%

6M Performance:

+79.67%

1Y Performance:

+91.92%

1-Day Range:

$1.52

$1.63

1-Week Range:

$1.48

$1.63

52-Week Range:

$0.5547

$1.63

Biofrontera Inc Stock (BFRI) Company Profile

Name

Biofrontera Inc

Sector

Healthcare (1074)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

781-245-1325

Address

120 PRESIDENTIAL WAY,, WOBURN

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

BFRI's Discussions on Twitter

Compare BFRI vs TAK, TEVA, HLN, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BFRI Biofrontera Inc	1.61	21.98M	43.20M	-11.09M	-9.32M	-1.1088
TAK Takeda Pharmaceutical Co Adr	18.45	57.90B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.36	42.89B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.60	43.41B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	75.81	31.00B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	487.61	22.35B	3.17B	1.29B	1.01B	27.09

Biofrontera Inc Stock (BFRI) Latest News

Aug 20, 2026

Biofrontera (BFRI) Q2 2026 Earnings Call Transcript - AOL.com

Aug 20, 2026

Aug 18, 2026

Biofrontera (BFRI) Close and Levels: Posts a 6.67% Gain to $1.44 in the Current Update; Trading Range: Price Remains Between $1.37 Support and $1.51 Resistance on the DayCall Spread Alert - Vinanet

Aug 18, 2026

Aug 14, 2026

Ziopharm: Q2 Earnings Snapshot - AOL.com

Aug 14, 2026

Biofrontera (BFRI) Climbs 3.17% to $1.30: Holding Above Key Support ZonePCR Divergence - vinanet.vn

Aug 14, 2026

Biofrontera Inc (BFRI)

Biofrontera Inc Stock (BFRI) Company Profile

Compare BFRI vs TAK, TEVA, HLN, ZTS, UTHR

Biofrontera Inc Stock (BFRI) Latest News

Biofrontera (BFRI) Q2 2026 Earnings Call Transcript - AOL.com

Biofrontera (BFRI) Close and Levels: Posts a 6.67% Gain to $1.44 in the Current Update; Trading Range: Price Remains Between $1.37 Support and $1.51 Resistance on the DayCall Spread Alert - Vinanet

Ziopharm: Q2 Earnings Snapshot - AOL.com

Biofrontera (BFRI) Climbs 3.17% to $1.30: Holding Above Key Support ZonePCR Divergence - vinanet.vn

Biofrontera Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Biofrontera Q2 2026 Earnings Call Transcript - marketbeat.com

Biofrontera Inc (BFRI) (Q2 2026) Earnings Call Highlights: Strong Ameluz Growth Drives Revenue ... - Yahoo Finance

Biofrontera Inc. (BFRI) lifts revenue yet flags going concern and ITC impact - Stock Titan

Biofrontera Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

BFRI Q2 2026 Earnings: Narrower-Than-Expected Loss Drives 6.4% Stock RallyEarnings Weakness Phase - vinanet.vn

Same Patent, Same Light- Director Vacates IPR Decision at Odds With ITC Decision - The National Law Review

Biofrontera earnings beat by $0.09, revenue topped estimates - Investing.com

Earnings call transcript: Biofrontera tops Q2 2026 estimates, shares jump 9.6% - Investing.com

BFRI: Record revenue growth, margin expansion, and strong pipeline offset ITC lamp restriction - TradingView

Biofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance

Price to earnings forward of Biofrontera Inc. – BOATS:BFRIW - TradingView

Biofrontera Inc. (BFRI) Q2 FY2026 earnings call transcript - Yahoo Finance

Form 8K Biofrontera Inc For: 13 August By Investing.com - Investing.com Australia

BIOFRONTERA ($BFRI) Releases Q2 2026 Earnings - Quiver Quantitative

Biofrontera Reports Q2 2026 Revenue Up 33% to $12.0M, Gross Margin 80% - TradingView

Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth - The Manila Times

Biofrontera (BFRI) investor Rosalind discloses 9.9% stake and 9.99% blocker - Stock Titan

Earnings To Watch: Biofrontera Inc (BFRI) Q2 2026 -- GF Value Sees 51% Downside - Yahoo Finance

Earnings To Watch: Biofrontera Inc (BFRI) Q2 2026 -- GF Value Se - GuruFocus

Biofrontera Inc. Warrants (BFRIW) Hold Steady at $0.03 as Support and Resistance ConvergeSuperTrend - vinanet.vn

Biofrontera Inc. (BFRI) Stock Major Holders - Yahoo! Finance Canada

Price to sales forward of Biofrontera Inc. – BOATS:BFRIW - TradingView

Biofrontera Inc (BFRI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Biofrontera Inc. (BFRI) stock price, news, quote and history - Yahoo Finance Singapore

BFRI Q1 2026 Earnings: EPS Misses Estimates by 215%, Shares Edge Down 0.8%EPS Miss Report - vinanet.vn

BFRI Q2'26 Earnings: EPS estimate is (0.10) USD - TradingView

Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026 - The Manila Times

Biofrontera schedules Aug. 13 webcast for business update - Stock Titan

Biofrontera (BFRI) Q1 2026 Earnings: Deep EPS Miss Reflects Rising Costs and Pipeline PressureRevenue Growth Outlook - vinanet.vn

BFRI Q2'26 Earnings: revenue estimate is 9.50M USD - TradingView

Form 4 Biofrontera Inc For: 29 July By Investing.com - Investing.com Canada

Biofrontera Inc. (BFRI) Q1 2026 Earnings: EPS Misses Estimates Sharply Despite Share GainEPS Guidance Update - dars.gov.et

Biofrontera Inc. Revenue Breakdown – NASDAQ:BFRI - TradingView

PTA-Adhoc: Biofrontera AG: Biofrontera AG Resolves to Prepare Transfer from the Regulated Market (Prime Standard) to the Scale Segment - TradingView

Biofrontera AG Resolves to Prepare Transfer from the Regulated Market (Prime Standard) to the Scale Segment - TradingView

BFRI|Biofrontera Inc|Price:1.050|Chg%:-0.040 - TradingKey

Biofrontera Inc. Revenue Breakdown – NASDAQ:BFRIW - TradingView

Biofrontera Inc (BFRI) Cash Flow - TradingKey

Biofrontera Inc (BFRI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Biofrontera Inc (BFRI) Income Statement - TradingKey

Biofrontera Inc (BFRI) Balance Sheet - TradingKey

Biofrontera Inc (BFRI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Biofrontera Inc (BFRI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Biofrontera Inc (BFRI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Biofrontera Inc. Revenue Breakdown – BOATS:BFRIW - TradingView

Biofrontera Inc. (BFRI) Holds Steady at $1.09: Consolidation Phase for Micro-Cap Pharma StockInverse ETF Flow - dars.gov.et

Biofrontera Inc Stock (BFRI) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to BFRI